IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T cell expansion without lymphopenia

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7265-7275

  Boyman, Onur ^a,c   Ramsey, Chris ^a   Kim, David M ^a   Sprent, Jonathan ^b   Surh, Charles D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; INTERLEUKIN 7; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL MATURATION; COMPLEX FORMATION; CONTROLLED STUDY; HOMEOSTASIS; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; ANTIGEN ANTIBODY COMPLEX; C57BL MOUSE; CELL PROLIFERATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; HOMEOSTASIS; IMMUNOLOGIC MEMORY; INTERLEUKIN-7; LYMPHOPENIA; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 47249097468     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7265     Document Type: Article

References (69)

1. Fry, T. J., and C. L. Mackall. 2005. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174: 6571-6576.
2. Sugamura, K., H. Asao, M. Kondo, N. Tanaka, N. Ishii, K. Ohbo, M. Nakamura, and T. Takeshita. 1996. The interleukin-2 receptor Y-chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu. Rev. Immunol. 14: 179-205.
3. Malek, T. R., and A. L. Bayer. 2004. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4: 665-674.
4. Sharfe, N., H. K. Dadi, M. Shahar, and C. M. Roifman. 1997. Human immune disorder arising from mutation of the α-chain of the intcrleukin-2 receptor. Proc. Natl. Acad. Sci. USA 94: 3168-3171.
5. Link, A., T. K. Vogt, S. Favre, M. R. Britschgi, H. Acha-Orbea, B. Hinz, J. G. Cyster, and S. A. Luther. 2007. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat. Immunol. 8: 1255-1265.
6. Surh, C. D., and J. Sprent. 2005. Regulation of mature T cell homeostasis. Semin Immunol. 17: 183-191.
7. von Freeden-Jeffry, U., P. Vieira, L. A. Lucian, T. McNeil, S. E. G. Burdach, and R. Murray. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181: 1519-1526.
8. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771-780.
9. Rosenberg, S. A., J. C. Yang, D. E. White, and S. M. Steinberg. 1998. Durability of complete responses in patients with melastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann. Surg. 228: 307-319.
10. Atkins, M. B., M. T. Lotze, J. P. Dutcher, R. I. Fisher, G. Weiss, K. Margolin, J. Abrams, M. Sznol, D. Parkinson, M. Hawkins, et al. 1999. High-dose recom-binant interleukin 2 therapy for patients with melastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J. Clin. Oncol. 17: 2105-2116.
11. Rao, B. M., I. Driver, D. A. Lauffenburger, and K. D. Wittrup. 2005. High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth. Biochemistry 44: 10696-10701.
12. Katre, N. V., M. J. Knauf, and W. J. Laird. 1987. Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Proc. Natl. Acad. Sci. USA 84: 1487-1491.
13. Melder, R. J., B. L. Osborn, T. Riccobene, P. Kanakaraj, P. Wei, G. Chen, D. Stolow, W. G. Halpern, T. S. Migone, Q. Wang, et al. 2005. Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice. Cancer Immunol. Immunother. 54: 535-547.
14. Boyman, O., M. Kovar, M. P. Rubinstein, C. D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927.
15. Klein, B., and H. Brailly. 1995. Cytokine-binding proteins: stimulating antagonists. Immunol. Today 16: 216-220.
16. Finkelman, F. D., K. B. Madden, S. C. Morris, J. M. Holmes, N. Boiani, I. M. Katona, and C. R. Maliszewski. 1993. Anti-cytokine antibodies as carrier proteins: prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J. Immunol. 151: 1235-1244.
17. Rubinstein, M. P., M. Kovar, J. F. Purton, J. H. Cho, O. Boyman, C. D. Surh, and J. Sprent. 2006. Converting IL-15 to a superagonist by binding to soluble IL-15Rα. Proc. Natl. Acad. Sci. USA 103: 9166-9171.
18. Stoklasek, T. A., K. S. Schluns, and L. Lefrancois. 2006. Combined IL-15/IL-15Rα immunotherapy maximizes IL-15 activity in vivo. J. Immunol. 177: 6072-6080.
19. + cells driven by IL-2. J. Exp. Med. 204: 1787-1801.
20. + T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. J. Exp. Med. 204: 1803-1812.
21. + T cells. Cell 71: 1205-1214.
22. Hogquist, K. A., S. C. Jameson, and M. J. Bevan. 1994. The ligand for positive selection of T lymphocytes in the thymus. Curr. Opin. Immunol. 6: 273-278.
23. Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R. M. Zinkemagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559-561.
24. Oxenius, A., M. F. Bachmann, R. M. Zinkemagel, and H. Hengartner. 1998. Virus-specific MHC-class H-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28: 390-400.
25. Miller, J. F. 1960. Studies on mouse leukaemia: the role of the thymus in leukaemogenesis by cell-free leukaemic filtrates. Br. J. Cancer 14: 93-98.
26. Grabstein. K. II., T. J. Waldschmidt, F. D. Finkelman, B. W. Hess. A. R. Alpert, N. E. Boiani, A. E. Namen, and P. J. Morrissey. 1993. Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J. Exp Med. 178: 257-264.
27. Sudo, T., S. Nishikawa, N. Ohno, N. Akiyama, M. Tamakoshi, and H. Yoshida. 1993. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc. Natl. Acad. Sci. USA 90: 9125-9129.
28. Mosmann, T. R., M. W. Bond, R. L. Coffman, J. Ohara, and W. E. Paul. 1986. T-cell and mast cell lines respond to B-cell stimulatory factor I. Proc. Natl. Acad. Sci. USA 83: 5654-5658.
29. + memory T cells by opposing cytokines. Science 288: 675-678.
30. Tan, J. T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K. I. Weinberg, and C. D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 98: 8732-8737.
31. + T cells in vivo. J. Immunol 169: 5622-5629.
32. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajae, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177-187.
33. von Freeden-Jeffry, U., N. Solvason, M. Howard, and R. Murray. 1997. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7: 147-154.
34. Ernst, B., D.-S. Lee, J. M. Chang, J. Sprent, and C. D. Surh. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11: 173-181.
35. + T cells in Iymphopenic hosts. Immunity 11: 183-190.
36. Murali-Krishna, K., and R. Ahmed. 2000. Naive T cells masquerading as memory cells. J. Immunol. 165: 1733-1737.
37. Schluns, K. S., W. C. Kieper, S. C. Jameson, and L. Lefrancois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1: 426-432.
38. Goodwin, R. G., S. Lupton, A. Schmierer, K. J. Hjerrild, R. Jerzy, W. Clevenger, S. Gillis, D. Cosman, and A. E. Namen. 1989. Human interleukin 7: molecular cloning and growth factor activity on human and murine B-Iineage cells. Proc. Natl. Acad. Sci. USA 86: 302-306.
39. Parham, P. 1983. On the fragmentation of monoclonal IgGl, IgG2a, and IgG2b from BALB/c mice. J. Immunol. 131: 2895-2902.
40. + memory T cells are IL-15 dependent. J. Exp. Med 204: 951-961.
41. Namen, A. E., S. Lupton, K. Hjerrild, J. Wignall, D. Y. Mochizuki, A. Schmierer, B. Mosley, C. J. March, D. Urdal, and S. Gillis. 1988. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 333: 571-573.
42. Conlon, P. J., P. J. Morrissey, R. P. Nordan, K. H. Grabstein, K. S. Prickett, S. G. Reed, R. Goodwin, D. Cosman, and A. E. Namen. 1989. Murine thymo-cytes proliferate in direct response to interleukin-7. Blood 74: 1368-1373.
43. Peschon, J. J., P. J. Morrissey, K. H. Grabstein, F. J. Ramsdell, E. Maraskovsky, B. C. Gliniak, L. S. Park, S. F. Ziegler, D. E. Williams, C. B. Ware, et al. 1994. Early lymphocyte expansion is severly impaired in interleukin 7 receptor-deficient mice. J. Exp. Med 180: 1955-1960.
44. + severe combined immunodeficiency. Nat. Genet. 20: 394-397.
45. Ma, A., R. Koka, and P. Burkett. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24: 657-679.
46. Surh, C. D., O. Boyman, J. F. Purton, and J. Sprent. 2006. Homeostasis of memory T cells. Immunol. Rev. 211: 154-163.
47. Baccala, R., D. Witherden, R. Gonzalez-Quintial, W. Dummer, C. D. Surh, W. L. Havran, and A. N. Theofilopoulos. 2005. γ δ T cell homeostasis is controlled by IL-7 and IL-15 together with subset-specific factors. J. Immunol. 174: 4606-4612.
48. Matsuda, J. L., L. Gapin, S. Sidobre, W. C. Kieper, J. T. Tan, R. Ceredig, C. D. Surh, and M. Kronenberg. 2002. Homeostasis of V a I4i NKT cells. Nat. Immunol. 3: 966-974.
49. + regulatory T cells. J. Immunol. 171: 5678-5682.
50. Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J: Exp. Med 203: 1693-1700.
51. Komschlies, K. L., T. A. Gregorio, M. E. Gruys, T. C. Back, C. R. Faltynek, and R. H. Wiltrout. 1994. Administration of recombinant human IL-7 to mice alters the composition of B-Iineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases. J. Immunol. 152: 5776-5784.
52. Geiselhart, L. A., C. A. Humphries, T. A. Gregorio, S. Mou, J. Subleski, and K. L. Komschlies. 2001. IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. J. Immunol. 166: 3019-3027.
53. + memory Cell pool. J. Clin. Invest. 115: 1177-1187.
54. Morrissey, P. J., P. Conlon, S. Braddy, D. E. Williams, A. E. Namen, and D. Y. Mochizuki. 1991. Administration of IL-7 to mice with cyclophosphamideinduced lymphopenia accelerates lymphocyte repopulation. J. Immunol. 146: 1547-1552.
55. Morrissey, P. J., P. Conlon, K. Charrier, S. Braddy, A. Alpert, D. Williams, A. E. Namen, and D. Mochizuki. 1991. Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral Iymphadenopathy. J. Immunol. 147: 561-568.
56. Bolotin, E., M. Smogorzewska, S. Smith, M. Widmer, and K. Weinberg. 1996. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 88: 1887-1894.
57. Mackall, C. L., T. J. Fry, C. Bare, P. Morgan, A. Galbraith, and R. E. Gress. 2001. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 97: 1491-1497.
58. Fry, T. J., M. Moniuszko, S. Creekmore, S. J. Donohue, D. C. Douek, S. Giardina, T. T. Hecht, B. J. Hill, K. Komschlies, J. Tomaszewski, et al. 2003. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood. 101: 2294-2299.
59. + T-regulatory cells. J. Immunother. 29: 313-319.
60. Sportes, C, and R. E. Gress. 2007. Interleukin-7 immunotherapy. Adv. Exp. Med. Biol. 601: 321-333.
61. Sato, J., N. Hamaguchi, K. Doken, K. Gotoh, K. Ootsu, S. Iwasa, Y. Ogawa, and H. Toguchi. 1993. Enhancement of anti-tumor activity of recombinant interleukin-2 (rIL-2) by immunocomplexing with a monoclonal antibody against rIL-2. Biotherapy 6: 225-231.
62. Courtney, L. P., J. L. Phelps, and L. M. Karavodin. 1994. An anti-IL-2 antibody increases serum half-life and improves anti-tumor efficacy of human recombinant interIeukin-2. Immunopharmacology 28: 223-232.
63. Valenzona, H. O., S. Dhanoa, F. D. Finkelman, and D. G. Osmond. 1998. Exogenous interleukin 7 as a proliferative stimulant of early precursor B cells in mouse bone marrow: efficacy of IL-7 injection, IL-7 infusion and IL-7-anti-IL-7 antibody complexes. Cylokine 10: 404-412.
64. Kamimura, D., Y. Sawa, M. Sato, E. Agung, T. Hirano, and M. Murakami. 2006. IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb. J. Immunol. 177:306-314.
65. Phelan, J. D., T. Orekov, and F. D. Finkelman. 2008. Cutting edge: mechanism of enhancement of in vivo cytokine effects by anti-cytokine monoclonal antibodies. J. Immunol. 180: 44-48.
66. Roopenian, D. C, and S. Akilesh. 2007. FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7: 715-725.
67. Davis, C. B., and S. D. Gillies. 2003. Immunocytokines: amplification of anti-cancer immunity. Cancer Immunol. Immunother. 52: 297-308.
68. Dela Cruz, J. S., T. H. Huang, M. L. Penichet, and S. L. Morrison. 2004. Anti-body-cytokine fusion proteins: innovative weapons in the war against cancer. Clin. Exp. Med. 4: 57-64.
69. Kovanen, P. E., and W. J. Leonard. 2004. Cytokines and immunodeficiency diseases: critical roles of the γ (c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 202: 67-83.